IN BRIEF: NEJM, stem cell source
NEJM & STEM CELLS: the New England Journal of Medicine has again expressed its strong support for therapeutic cloning. The deputy editor of the prestigious journal, Dr Robert S. Schwartz, wrote in an official commentary in the current issue that ” Research on stem cells will encounter many twists and turns, but it is an endeavour that is eminently worth pursuing. The delay of medical advances by theological disputes is not in the best interests of the sick and disabled.”
Michael Cook edits BioEdge, a bioethics newsletter, and MercatorNet, an on-line magazine whose focus is human dignity. He writes from Sydney, Australia.
Latest posts by Michael Cook (see all)
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicide—again - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
More Stories
War and peace: Israeli physicians treating Palestinian patients
In the midst of the bitter war between Hamas and the Israeli Defense Forces in Gaza, there is a ray...
Court rules ‘voluntary assisted dying’ is suicide
Such is the stigma surrounding suicide that advocates of “voluntary assisted dying” insist vehemently that it is by no means...
Is poverty a cause of the rise of trans identity in the UK?
UK rates of transgender identity have risen at least 5-fold since 2000, with the highest rise observed among 16 to...
Donor anonymity becomes a battleground in the US
Donor-conceived Americans who want the federal government to abolish donor anonymity are getting pushback from the LGBTQI+ lobby. On the...
Should there be a ‘dead donor rule’ for sperm donation?
Sperm donation creates a web of exceedingly complex relationships. The HeyReprotech Newsletter (a great Substack resource for news about assisted...
The oldest mother in Africa is single and broke
A 70-year-old Ugandan woman has given birth to twins after receiving IVF treatment. Safina Namukwaya delivered a boy and a...